Ibrutinib - Globe Thesis

Keyword [Ibrutinib] Result: 21 - 40 \| Page: 2 of 3
21.	Study Of Ibrutinib In CCRF-CEM Cell Lins Proliferation And Induction Of Apoptosis
22.	New Treatment For The Treatment Of Chronic Lymphocytic Leukemia
23.	Synthesis,Structural Modification And Biological Evaluation Of Ibrutinib
24.	The Anticancer Mechanism Of Ibrutinib And Eupalinolide A Targeting Thioredoxin Reductase
25.	Ibrutinib,a Bruton's Tyrosine Kinase Inhibitor,exhibits Anti-Tumoral Activity And Induces Autophagy In Glioblastoma
26.	Arsenic Trioxide Increases Sensitivity Of Mantle Cell Lymphoma Cell Line To Ibrutinib By Reducing C-MYC Expression
27.	Synthesis Of 4,5-Difunctionalized Pyrazoles
28.	Exploration Of A Novel Genetic Predictive Model And Precision Treatment For Early Progression Of Diffuse Large B-cell Lymphoma
29.	Preparation And Properties Study Of New Amorphous Form Of Ibrutinib
30.	The Effect Of Wenxin Granule On The Electrophysiology Of Atrial Muscle In Mice With Atrial Fibrillation Induced By Ibrutinib And Its Molecular Mechanism
31.	Kinase Targeting Therapies in Chronic Lymphocytic Leukemia: Mechanisms of Acquired Ibrutinib Resistance and the Pre-Clinical Development of OSU-T315
32.	Structural Modification Based On Ibrutinib And Biologica Evaluation In Mantle Cell Lymphoma
33.	Effect Mechanism Of Wenxin Granule Regulating Oxidative Stress And Calcium Cycle In The Prevention And Treatment Of Ibrutinib-induced Atrial Fibrillation
34.	Study Of Effects Of HSP90 Inhibitor Ganetespib On The Sensitivity Of Mantle Cell Lymphoma To The BTK Inhibitor Ibrutinib And The Relevant Mechanisms
35.	The Clinical Characteristics And Prognosis Of Waldenstrom Macroglobulinemia:A Retrospective Analysis
36.	Clinical Efficacy Of Ibrutinib Monotherapy And R-CHOP In The Treatment Of Chronic Lymphocytic Leukemia
37.	The Effect And Mechanism Of Berberamine Combined With Ibrutinib On Acute Myeloid Leukemia Cells
38.	BTK Regulate P-gp-mediated Drug-resistance In Acute Lymphoblastic Leukemia
39.	Study On The Mechanism Of Venetoclax Combined With Ibrutinib In Mediating The Programmed Necrosis Of Central Lymphoma
40.	Single Center Retrospective Analysis Of Treatment Choice And Survival In 284 Cases Of Chronic Lymphoblastic Leukemia
<<First <Prev Next> Last>> Jump to